Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK VTI ARKG IWM VXF IWN IBB VTWO SCHA VHT

Index	RUT	P/E	-	EPS (ttm)	-2.27	Insider Own	11.96%	Shs Outstand	300.35M	Perf Week	-4.00%
Market Cap	360.44M	Forward P/E	-	EPS next Y	-0.51	Insider Trans	-0.09%	Shs Float	264.44M	Perf Month	-2.44%
Enterprise Value	744.62M	PEG	-	EPS next Q	-0.15	Inst Own	55.96%	Short Float	14.03%	Perf Quarter	0.00%
Income	-525.16M	P/S	2.31	EPS this Y	-50.51%	Inst Trans	-18.71%	Short Ratio	4.66	Perf Half Y	-1.64%
Sales	156.11M	P/B	5.86	EPS next Y	69.72%	ROA	-44.98%	Short Interest	37.11M	Perf YTD	-34.43%
Book/sh	0.20	P/C	1.14	EPS next 5Y	28.08%	ROE	-189.52%	52W High	2.72 -55.88%	Perf Year	-28.57%
Cash/sh	1.05	P/FCF	-	EPS past 3/5Y	-21.38% -23.55%	ROIC	-69.10%	52W Low	0.85 40.99%	Perf 3Y	-80.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.67% 11.12%	Gross Margin	-215.73%	Volatility	6.62% 5.89%	Perf 5Y	-81.57%
Dividend TTM	-	EV/Sales	4.77	EPS Y/Y TTM	-19.34%	Oper. Margin	-364.72%	ATR (14)	0.08	Perf 10Y	-74.52%
Dividend Ex-Date	-	Quick Ratio	6.02	Sales Y/Y TTM	-17.35%	Profit Margin	-336.40%	RSI (14)	42.80	Recom	2.31
Dividend Gr. 3/5Y	- -	Current Ratio	6.92	EPS Q/Q	78.04%	SMA20	-6.29%	Beta	2.11	Target Price	2.00
Payout	-	Debt/Eq	11.37	Sales Q/Q	10.42%	SMA50	-12.40%	Rel Volume	0.89	Prev Close	1.17
Employees	575	LT Debt/Eq	11.36	Earnings	Aug 07 AMC	SMA200	-15.93%	Avg Volume	7.96M	Price	1.20
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.70% 8.61%	Trades		Volume	7,051,290	Change	2.56%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Today 11:46AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Sep-14-25 11:36PM	Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest (StockStory)
Sep-12-25 06:15PM	Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today (Zacks) -7.14%
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
Sep-03-25 09:05AM	PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow (GlobeNewswire)
02:25PM	Loading…
Aug-22-25 02:25PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +9.52%
Aug-19-25 01:51PM	Cathie Woods ARK Innovation Sees Outflows, But Buys More Deere Stock Anyway (Barrons.com)
Aug-14-25 01:34AM	The Top 5 Analyst Questions From PacBio's Q2 Earnings Call (StockStory)
Aug-13-25 03:01PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +5.79%
Aug-11-25 09:38AM	PACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive Results (StockStory) -6.67%
Aug-08-25 12:21PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +7.14%
12:07PM	PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises (Zacks)
Aug-07-25 07:30PM	Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -8.70%
07:00PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:58PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press Finance)
05:07PM	Loading…
05:07PM	PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars (StockStory)
04:05PM	PacBio Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-06-25 05:50PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-05-25 11:18PM	PacBio (PACB) Q2 Earnings Report Preview: What To Look For (StockStory)
Aug-04-25 09:15AM	Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
09:05AM	Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models (GlobeNewswire)
Jul-31-25 12:03AM	3 Reasons to Avoid PACB and 1 Stock to Buy Instead (StockStory) -7.38%
Jul-29-25 06:15PM	Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights (Zacks) -6.10%
03:30PM	PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know (StockStory)
09:35AM	Pacific Biosciences (PACB) Jumps 6.5% Ahead of Earnings (Insider Monkey)
08:52AM	Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing (PR Newswire)
Jul-24-25 09:05AM	PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications (GlobeNewswire) -8.88%
Jul-23-25 01:11PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
09:05AM	PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio (GlobeNewswire)
04:05PM	Loading…
Jul-22-25 04:05PM	QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels (Business Wire) +11.72%
Jul-21-25 04:05PM	PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire) +5.84%
Jul-17-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks) -6.71%
Jul-10-25 06:15PM	Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Jul-09-25 11:57AM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jul-08-25 12:00PM	Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jul-03-25 09:08AM	Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue (Insider Monkey) +7.38%
Jun-30-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:50AM	The 5 Most Interesting Analyst Questions From PacBio's Q1 Earnings Call (StockStory)
Jun-13-25 11:30AM	Why Is Steris (STE) Down 1.8% Since Last Earnings Report? (Zacks)
Jun-12-25 06:15PM	Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know (Zacks)
Jun-10-25 06:41AM	PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds (StockStory)
Jun-05-25 12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jun-04-25 11:31PM	Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment (StockStory)
Jun-02-25 10:00AM	Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date (PR Newswire)
May-29-25 12:00PM	All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy (Zacks) -5.45%
May-28-25 09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) +20.85%
May-23-25 10:46AM	PacBio Stock Slips Despite New China Distribution Deal With Haorui (Zacks)
May-22-25 09:05AM	PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene (GlobeNewswire)
May-12-25 01:04PM	PACB Stock May Rise Following the Deal With Chulalongkorn University (Zacks)
10:56AM	PacBio Board Independent Investigation Concludes Allegations Unsubstantiated (GlobeNewswire)
May-09-25 12:00PM	PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates (Zacks) -6.67%
May-08-25 09:00PM	Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) +6.19%
05:30PM	Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:29PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	PacBio Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 12:38PM	Pacific Biosciences of California Q1 2025 Earnings Preview (Seeking Alpha)
11:08AM	Earnings To Watch: Pacific Biosciences of California Inc (PACB) Reports Q1 2025 Result (GuruFocus.com)
May-05-25 09:05AM	First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand (GlobeNewswire)
Apr-29-25 06:15PM	Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Apr-28-25 09:05AM	PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry (GlobeNewswire)
09:01AM	1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar (StockStory)
Apr-23-25 06:15PM	Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know (Zacks)
Apr-22-25 09:05AM	Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa (GlobeNewswire)
Apr-09-25 02:38PM	PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know (StockStory) +20.83%
09:05AM	PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million (GlobeNewswire)
Apr-04-25 07:45PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +7.32%
Mar-27-25 09:05AM	Jim Gibson to join PacBio as Chief Financial Officer (GlobeNewswire)
Mar-20-25 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
01:05PM	Here's Why You Should Retain PacBio Stock in Your Portfolio Now (Zacks)
Mar-18-25 06:15PM	Is Pacific Biosciences of California, Inc. (PACB) the Most Volatile Stock Under $3 For Day Trading? (Insider Monkey)
05:08AM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
Mar-17-25 09:05AM	Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes (GlobeNewswire)
05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-14-25 06:15PM	Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
Mar-11-25 09:01AM	1 Healthcare Stock to Target This Week and 2 to Turn Down (StockStory) -5.76%
Feb-19-25 04:05PM	PacBio to Participate in TD Cowen's 45th Annual Health Care Conference (GlobeNewswire) -5.35% -7.34%
Feb-15-25 11:02AM	PacBio should return to growth over time, says Canaccord (TipRanks)
Feb-14-25 11:09PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +25.00%
02:21AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Feb-13-25 06:00PM	Compared to Estimates, Pacific Biosciences (PACB) Q4 Earnings: A Look at Key Metrics (Zacks) +8.82%
05:20PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:13PM	PacBio (NASDAQ:PACB) Misses Q4 Sales Targets (StockStory)
04:28PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results (GlobeNewswire)
Feb-12-25 08:03AM	PacBio (PACB) Q4 Earnings Report Preview: What To Look For (StockStory)
07:42AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-04-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why (Zacks) +13.89%
Feb-03-25 09:05AM	PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service (GlobeNewswire) -5.19%
Jan-30-25 04:05PM	PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025 (GlobeNewswire)
09:05AM	PacBio Announces Appointment of Chris Smith to Board of Directors (GlobeNewswire)
Jan-29-25 09:05AM	PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics (GlobeNewswire)
Jan-27-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -1.18%: What You Should Know (Zacks)
Jan-24-25 09:16AM	PacBio announces GIFS at USask as first Revio PacBio CSP in Canada (TipRanks)
Jan-23-25 09:05AM	PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider (GlobeNewswire) -8.84%
Jan-14-25 09:05AM	PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics (GlobeNewswire) -7.96%
09:00AM	PacBio Announces Preliminary Fourth Quarter and Full Year Revenue (GlobeNewswire)
Jan-10-25 06:05AM	PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing (GlobeNewswire)
Jan-08-25 09:05AM	PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets (GlobeNewswire)
Jan-07-25 06:15PM	Why the Market Dipped But Pacific Biosciences of California (PACB) Gained Today (Zacks)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '25	Sale	1.41	12,497	17,583	2,225,357	Mar 05 04:37 PM
Van Oene Mark	See Remarks	Mar 03 '25	Sale	1.41	6,486	9,126	1,497,695	Mar 05 04:37 PM
Farmer Michele	See Remarks	Mar 03 '25	Sale	1.41	2,973	4,183	184,619	Mar 05 04:36 PM
MARK VAN OENE	Officer	Mar 03 '25	Proposed Sale	1.41	6,486	9,123		Mar 03 05:11 PM
CHRISTIAN HENRY	Officer	Mar 03 '25	Proposed Sale	1.41	12,497	17,578		Mar 03 05:06 PM
Farmer Michele	See Remarks	Feb 18 '25	Sale	1.88	24,349	45,727	187,592	Feb 19 05:00 PM
Van Oene Mark	See Remarks	Feb 18 '25	Sale	1.88	100,773	189,252	1,496,681	Feb 19 04:59 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '25	Sale	1.88	259,909	488,109	2,237,854	Feb 19 04:58 PM
CHRISTIAN HENRY	Officer	Feb 18 '25	Proposed Sale	1.88	259,909	488,109		Feb 18 05:59 PM
MARK VAN OENE	Officer	Feb 18 '25	Proposed Sale	1.88	100,773	189,252		Feb 18 05:56 PM
Van Oene Mark	See Remarks	Jan 10 '25	Sale	2.03	34,405	69,980	1,597,454	Jan 10 04:54 PM
MARK VAN OENE	Officer	Jan 10 '25	Proposed Sale	2.03	34,405	69,980		Jan 10 04:23 PM
Kim Susan G.	See Remarks	Sep 30 '24	Sale	1.72	19,782	34,065	695,654	Oct 02 04:13 PM
SUSAN KIM	Officer	Sep 30 '24	Proposed Sale	1.72	19,782	34,061		Sep 30 04:03 PM
HENRY CHRISTIAN O	See Remarks	Sep 16 '24	Sale	1.75	98,907	172,692	2,497,763	Sep 17 04:11 PM
CHRISTIAN HENRY	Officer	Sep 16 '24	Proposed Sale	1.75	98,907	172,741		Sep 16 05:40 PM

Open in Screener

MRNA

Moderna Inc

Sep 15 • 04:00PM ET

23.88

+0.37 1.57 %

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI VB VOO VBR RSP XBI SPY IVV XLV IBB

Index	S&P 500	P/E	-	EPS (ttm)	-7.52	Insider Own	11.70%	Shs Outstand	389.00M	Perf Week	-3.83%
Market Cap	9.29B	Forward P/E	-	EPS next Y	-7.51	Insider Trans	-0.00%	Shs Float	343.56M	Perf Month	-10.53%
Enterprise Value	4.90B	PEG	-	EPS next Q	-2.05	Inst Own	73.78%	Short Float	17.42%	Perf Quarter	-10.46%
Income	-2903.00M	P/S	3.02	EPS this Y	-4.03%	Inst Trans	3.16%	Short Ratio	6.11	Perf Half Y	-31.02%
Sales	3.08B	P/B	0.99	EPS next Y	22.16%	ROA	-20.97%	Short Interest	59.84M	Perf YTD	-42.57%
Book/sh	24.16	P/C	1.81	EPS next 5Y	18.81%	ROE	-27.50%	52W High	75.37 -68.32%	Perf Year	-69.97%
Cash/sh	13.19	P/FCF	-	EPS past 3/5Y	- -42.94%	ROIC	-28.75%	52W Low	23.15 3.15%	Perf 3Y	-83.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-43.99% 121.86%	Gross Margin	45.74%	Volatility	5.47% 4.56%	Perf 5Y	-56.05%
Dividend TTM	-	EV/Sales	1.59	EPS Y/Y TTM	51.07%	Oper. Margin	-106.34%	ATR (14)	1.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.77	Sales Y/Y TTM	-38.95%	Profit Margin	-94.31%	RSI (14)	39.35	Recom	2.89
Dividend Gr. 3/5Y	- -	Current Ratio	3.93	EPS Q/Q	36.16%	SMA20	-5.24%	Beta	2.00	Target Price	43.37
Payout	-	Debt/Eq	0.08	Sales Q/Q	-41.08%	SMA50	-15.73%	Rel Volume	1.22	Prev Close	23.51
Employees	5800	LT Debt/Eq	0.07	Earnings	Aug 01 BMO	SMA200	-24.34%	Avg Volume	9.79M	Price	23.88
IPO	Dec 07, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	28.75% 28.16%	Trades		Volume	11,934,114	Change	1.57%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60

Show Previous Ratings

Today 08:56AM	COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths (Zacks)
04:00AM	Moderna and BioNTech pioneered mRNA vaccines. But who will make a mark in therapeutics? (Pharma Voice)
Sep-14-25 05:30AM	Biotech stocks: Who wins and who loses if RFK, Jr. goes (Investing.com)
Sep-13-25 01:56PM	Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths (FastCompany)
Sep-12-25 07:55PM	Review & Preview: Waiting for the Rate Cut (Barrons.com) -7.40%
07:43PM	Loading…
07:43PM	Drugmakers Fall on Report US to Claim Covid Shot Killed Kids (Bloomberg)
05:45PM	Moderna (MRNA) Declines More Than Market: Some Information for Investors (Zacks)
05:16PM	S&P 500 Gains and Losses Today: Warner Bros. and Paramount Extend Gains; Moderna Plunges (Investopedia)
05:15PM	These Stocks Moved the Most Today: Warner Bros., Paramount Skydance, Tesla, Moderna, IonQ, Gemini Space, Microsoft, and More (Barrons.com)
04:21PM	Vaccine Stocks Fall Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
04:01PM	Why Moderna (MRNA) Shares Are Trading Lower Today (StockStory)
02:56PM	Vaccine Stocks Fall on Reports FDA Will Allege Link Between Covid-19 Shots and Child Deaths (Barrons.com)
02:25PM	These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Moderna, IonQ, Gemini Space, Microsoft, and More (Barrons.com)
02:11PM	Vaccine Stocks Down Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
01:37PM	COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says (MarketWatch)
01:28PM	Loading…
01:28PM	Sept. consumer sentiment falls, Moderna & COVID report, Gemini IPO (Yahoo Finance Video)
12:33PM	Pfizer, Moderna, BioNTech trade lower amid report of vaccine link to child deaths (Investing.com)
12:11PM	Trump officials to link child deaths to COVID shots, Washington Post reports (Reuters)
11:35AM	Stock Market Today: Investors await opening trade from Gemini, Via, and Legence (TheStreet)
03:00AM	Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl (Barrons.com)
Sep-11-25 10:05AM	Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock? (Zacks)
08:06AM	Which Investments Do the Uber-Rich Favor? This Wall Street Pro Knows. (Barrons.com)
Sep-10-25 04:00AM	Pharmas new boomtown? Why drugmakers are setting up shop in a small Swiss city. (Pharma Voice)
Sep-09-25 08:00PM	Health Officials Hunt for Cases Connecting Covid Shot and Harm in Pregnant Women (The Wall Street Journal)
Sep-08-25 02:26PM	Why Moderna (MRNA) Shares Are Falling Today (StockStory)
01:41PM	Amid Vaccine Controversy, Pfizer Says New Covid Shots Are Effective (Barrons.com)
Sep-07-25 02:28PM	I Thought Of Moderna, Inc. (MRNA) After Florida's Vaccine Rules, Says Jim Cramer (Insider Monkey)
04:42AM	Is it Time to Dump Your Shares of Moderna? (Motley Fool)
Sep-05-25 11:33AM	Analyst Report: Moderna, Inc. (Morningstar Research)
10:27AM	Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? (Investor's Business Daily)
12:44AM	Loading…
Sep-04-25 12:44AM	1 Cash-Heavy Stock Worth Your Attention and 2 We Question (StockStory)
Sep-03-25 03:08PM	Analyst Report: Moderna, Inc. (Morningstar Research)
Sep-02-25 07:00AM	Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism (ACCESSWIRE)
04:57AM	Is Moderna Stock Underperforming the S&P 500? (Barchart)
01:34AM	Moderna (MRNA) Gains FDA Nod for Next-Gen COVID-19 Vaccine Targeting LP.8.1 Variant (Insider Monkey)
12:33AM	3 Healthcare Stocks with Warning Signs (StockStory)
Aug-31-25 08:40AM	Large-cap biotech is a sector to watch for investors: Analysts (Yahoo Finance)
Aug-29-25 11:51AM	Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Aug-28-25 12:04PM	FDA Approves Updated COVID-19 Vaccines but With Restrictions (Zacks)
07:55AM	FDA approves mRNA vaccines for new Covid-19 season amid political tension (Pharmaceutical Technology)
04:56AM	Moderna, Inc. (MRNA) Expands Into Oncology with Pan-Tumor Vaccine (Insider Monkey)
03:49AM	Analyst Report: Moderna, Inc. (Morningstar Research)
Aug-27-25 11:32PM	Reflecting On Therapeutics Stocks' Q2 Earnings: Moderna (NASDAQ:MRNA) (StockStory)
04:27PM	RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles. (Investor's Business Daily)
03:05PM	Why Moderna (MRNA) Stock Is Up Today (StockStory)
01:56PM	FDA Approves Pfizer Covid Vaccine but Adds Restrictions on Its Use (Barrons.com)
01:42PM	New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One. (The Wall Street Journal)
01:24PM	Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 (ACCESSWIRE)
Aug-26-25 08:31PM	Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' (Benzinga)
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) -6.53%
08:10AM	Modernas updated Covid-19 vaccine gets Canadian approval (Pharmaceutical Technology)
Aug-24-25 02:17AM	Moderna, Inc. (MRNA) Down 35% YTD. Here Is Why (Insider Monkey)
Aug-22-25 06:02PM	Moderna Stock Jumps After Canada Approves New Covid Vaccine (GuruFocus.com) -6.53%
09:25AM	Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 (ACCESSWIRE)
Aug-21-25 07:00AM	Moderna to Present at Upcoming Conferences in September 2025 (ACCESSWIRE)
Aug-20-25 04:23PM	Covid-19 Vaccine Guidelines Are Changing. What We Know About Who Can Get a Shot. (Barrons.com)
Aug-19-25 09:06AM	Can Keytruda Sustain Merck's Growth Through the Rest of 2025? (Zacks)
Aug-18-25 03:58AM	Biopharma layoffs rise as drugmakers tighten belts and reorganize (Pharma Voice)
Aug-17-25 09:30AM	If You're in Your 30s, Consider Buying These 2 Healthcare Stocks (Motley Fool)
Aug-14-25 09:00AM	U.S. mRNA Therapeutics CDMO Market to Hit Valuation of US$ 6.27 Billion by 2033 \| Astute Analytica (GlobeNewswire)
Aug-13-25 03:16PM	Moderna Stock Jumps as NIH Chief Tempers Administration's Attack on mRNA (Barrons.com)
07:30AM	[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
12:18AM	3 Reasons to Avoid MRNA and 1 Stock to Buy Instead (StockStory)
12:15AM	The 5 Most Interesting Analyst Questions From Moderna's Q2 Earnings Call (StockStory)
12:04AM	MRNA Q2 Deep Dive: Revenue Beat Overshadowed by Lower Guidance and Cost Cuts (StockStory)
Aug-12-25 02:20PM	Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know (StockStory)
Aug-11-25 09:17AM	Merck Stock Down 4% Since Q2 Results: How to Play the Stock (Zacks)
07:36AM	mRNA Platform Strategic Business Analysis Report 2025 \| Global Market to Reach $129.1 Billion by 2030 - Rising Infectious Diseases, Technological Advancements, and Pandemic Preparedness Drive Growth (GlobeNewswire)
05:22AM	The 3 Things That Matter for Moderna Now (Motley Fool)
Aug-09-25 06:35PM	Moderna, Inc. (MRNA)'s "Got The Double Whammy," Says Jim Cramer (Insider Monkey)
Aug-07-25 03:17PM	Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here? (Barchart)
10:16AM	Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma (GlobeNewswire)
07:34AM	RFK Jrs mRNA funding halt signals shift in US public health (Pharmaceutical Technology)
04:31AM	AI is already upending the corporate org chart as it flattens the distance between the C-suite and everyone else (Fortune)
Aug-06-25 06:22PM	Podcast: Stock Indexes Rise as Trump Boosts India Tariffs; Earnings in Focus (The Wall Street Journal)
03:27PM	RFK Jr. Ordered the HHS to Stop Funding mRNA Vaccine Development. The Edict Hit a Biotech Working on an Unrelated Treatment. (Barrons.com)
02:19PM	Moderna's stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals (MarketWatch)
08:08AM	Novavax beats quarterly revenue estimates on milestone payment (Reuters)
03:35AM	Moderna Stock: Is Wall Street Bullish or Bearish? (Barchart)
Aug-05-25 06:52PM	HHS to Wind Down mRNA Vaccine Programs (The Wall Street Journal)
06:00AM	Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034 (GlobeNewswire)
04:03AM	Cancer Vaccine Research Report 2025-2035 \| Market Accelerates with Key Players Like Merck and Moderna, Backed by Pharma-Biotech Collaborations and Academic Partnerships (GlobeNewswire)
Aug-04-25 05:07PM	Health Care Roundup: Market Talk (The Wall Street Journal)
Aug-02-25 03:05AM	Moderna Inc (MRNA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Cost ... (GuruFocus.com)
Aug-01-25 06:00PM	Here's What Key Metrics Tell Us About Moderna (MRNA) Q2 Earnings (Zacks) -6.61%
05:08PM	Stocks Sink as Bonds Jump on Deepening Jobs Cracks: Markets Wrap (Bloomberg)
04:10PM	Moderna Cuts Forecast, Stock Wobbles Despite Beat (GuruFocus.com)
03:47PM	What Companies Have Said About Jobs in the Past Quarter (The Wall Street Journal)
02:14PM	Moderna sharpens focus on $1.5bn cost cutting plan after 41% revenue slump (Pharmaceutical Technology)
01:21PM	MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View (Zacks)
12:59PM	Analyst Report: Moderna, Inc. (Morningstar Research)
12:20PM	Why Moderna (MRNA) Stock Is Trading Lower Today (StockStory)
11:38AM	These Stocks Are Moving the Most Today: Apple, Amazon, Figma, Fluor, Eastman Chemical, MicroStrategy, Coinbase, and More (Barrons.com)
10:33AM	Moderna Stock Is Falling After Earnings. What Has Wall Street Worried. (Barrons.com)
10:30AM	Moderna Stock Drops as Firm Cuts Revenue Outlook on UK Vaccine Deliveries Delay (Investopedia)
09:46AM	Coinbase, ExxonMobil & Chevron, Moderna: Trending Tickers (Yahoo Finance Video)
08:44AM	Moderna's Key Patent Win Overshadowed By Gloomy Outlook (Benzinga)
08:10AM	Moderna (MRNA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
08:06AM	Earnings live: Exxon, Chevron profits beat estimates, Moderna stock tumbles (Yahoo Finance)
08:06AM	Earnings live: Exxon, Chevron oil output boosts profits, Moderna stock tumbles (Yahoo Finance)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hussain Abbas	Director	Jun 11 '25	Sale	28.00	312	8,736	580	Jun 12 04:22 PM
Hussain Abbas	Director	Jun 11 '25	Proposed Sale	28.00	312	8,736		Jun 11 10:06 AM
Bancel Stephane	Chief Executive Officer	Mar 03 '25	Buy	31.22	160,314	5,004,318	9,210,686	Mar 04 04:27 PM
SAGAN PAUL	Director	Mar 03 '25	Buy	31.76	31,620	1,004,251	312,027	Mar 04 04:24 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 09 '24	Sale	44.68	529	23,637	20,446	Dec 10 04:08 PM
Klinger Shannon Thyme	Officer	Dec 09 '24	Proposed Sale	44.68	529	23,637		Dec 09 03:18 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 03 '24	Sale	43.30	112	4,849	19,837	Dec 04 05:11 PM
Hoge Stephen	President	Dec 03 '24	Sale	43.30	314	13,595	1,443,904	Dec 04 05:08 PM
Klinger Shannon Thyme	Officer	Dec 03 '24	Proposed Sale	43.30	112	4,849		Dec 03 04:11 PM
Hoge Stephen	Officer	Dec 03 '24	Proposed Sale	43.30	314	13,595		Dec 03 03:23 PM
Mock James M	Chief Financial Officer	Nov 29 '24	Sale	42.79	1,420	60,761	11,066	Dec 02 04:26 PM
Klinger Shannon Thyme	Chief Legal Officer	Nov 29 '24	Sale	42.79	1,418	60,675	19,717	Dec 02 04:19 PM
Hoge Stephen	President	Nov 29 '24	Sale	42.79	291	12,452	1,443,567	Dec 02 04:15 PM
Hoge Stephen	Officer	Nov 29 '24	Proposed Sale	42.79	291	12,452		Nov 29 03:54 PM
Klinger Shannon Thyme	Officer	Nov 29 '24	Proposed Sale	42.79	1,418	60,675		Nov 29 03:49 PM
Mock James M	Officer	Nov 29 '24	Proposed Sale	42.79	1,420	60,761		Nov 29 03:35 PM
Hoge Stephen	President	Nov 11 '24	Sale	46.10	277	12,771	1,443,248	Nov 12 04:14 PM
Hoge Stephen	Officer	Nov 11 '24	Proposed Sale	46.10	277	12,771		Nov 12 09:27 AM
Mock James M	Chief Financial Officer	Oct 07 '24	Sale	60.12	715	42,986	9,505	Oct 08 04:19 PM

PACB

Pacific Biosciences of California Inc

MRNA

Moderna Inc

Upgrade your FINVIZ experience